Byron P Delemos

Summary

Affiliation: Johnson and Johnson Pharmaceutical Research and Development
Country: USA

Publications

  1. ncbi Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial
    Byron P Delemos
    Ortho McNeil Janssen Scientific Affairs, LLC, Raritan, NJ 08869, USA
    Am J Ther 18:216-26. 2011

Detail Information

Publications1

  1. ncbi Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial
    Byron P Delemos
    Ortho McNeil Janssen Scientific Affairs, LLC, Raritan, NJ 08869, USA
    Am J Ther 18:216-26. 2011
    ..A large, increasing placebo response during the study may have contributed to the lack of statistical separation between tramadol ER 200 or 100 mg and placebo...